Johnson & Johnson Receives the CHMP Positive Opinion on Label Extension to SC Rybrevant for the Treatment of Advanced EGFR-Mutated...
Shots: The CHMP recommended label extension to SC Rybrevant (Q1W x 4wks, then Q2W)...
Bavarian Nordic Receives CHMP’s Positive Opinion for Vimkunya to Prevent Chikungunya
Shots: The CHMP has recommended Vimkunya (pre-filled syringe) against CHIKV diseas...
Novo Nordisk Reports the US FDA’s Approval for Ozempic to Reduce Risk of Kidney Disease Progression & Cardiovascular Death in Type...
Shots: The US FDA has approved Ozempic to reduce the risk of kidney disease w...
Merck Receives CHMP’s Positive Opinion for Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for Invasive Pneumococcal Disease...
Shots: The CHMP has recommended Capvaxive for active immunization against invasive...
AstraZeneca and Daiichi Sankyo Receive CHMP’s Positive Opinion for Datroway to Treat HR+/HER2- Breast Cancer
Shots: The CHMP has recommended Datroway to treat unresectable or metastatic HR+/H...
Sanofi Receives China’s NMPA Approval for Sarclisa + SoC VRd to Treat Newly Diagnosed Multiple Myeloma (NDMM)
Shots: China’s NMPA has approved Sarclisa with SoC VRd (bortezomib, len...
